Mimedx MDXG
NASDAQ MDXG
$3.74 -0.49 (-11.58%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mimedx (MDXG) Restructuring Costs (2023)

Updated

Mimedx (MDXG) reported Restructuring Costs of $208,000 for Q3 2023, down 93.6% from the prior quarter.

Analysis

Mimedx (MDXG) Restructuring Costs (2023) Analysis & Trends

Over the twelve months ended Sep 30, 2023, Mimedx's Restructuring Costs came in at $3.46 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Mimedx 559.41 Mn -44.41 Mn 44.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 208,000.00
Jun 30, 2023 3.26 Mn
API Access

Mimedx Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=MDXG&period=max&api_key=YOUR_API_KEY